lunes, 23 de julio de 2018

Continuing Education and Informational Resources | Community | Antibiotic Use | CDC

Continuing Education and Informational Resources | Community | Antibiotic Use | CDC

CDC TRAIN - an affiliate of the TRAIN Learning Network powered by the Public Health Foundation



Healthcare Professionals: Register Now for Free Continuing Education about Antibiotic Stewardship

Antibiotic Stewardship poster



Today, CDC’s Office of Antibiotic Stewardship launches the second section of a four-part web-based training course about antibiotic stewardship. While this particular course is primarily for clinicians who prescribe antibiotics, CDC recognizes that everyone plays an important role in improving antibiotic use. Physicians, nurse practitioners, physician assistants, certified health education specialists, nurses, pharmacists, and public health practitioners with a master’s degree in public health are all eligible to receive up to eight hours of free continuing education credit (CE). The first and second sections are available now, with sections three and four releasing later this year.
Topics in section two include:
  • background and errors in outpatient antibiotic use in the United States
  • inappropriate antibiotic use and opportunities for improvement
  • the Core Elements of Outpatient Antibiotic Stewardship
  • communication training to improve clinician-patient communication about appropriate antibiotic use
To learn more about this course, as well as other continuing education opportunities, visit the CDC Antibiotic Use Continuing Education page.
This course fulfills Improvement Activities (IA) Patient Safety and Practice Assessment (PSPA)_23 and PSPA_24 under the Centers for Medicare & Medicaid Services (CMS) Merit-Based Incentive Programs, or MIPS.
Create an account and register for this course directly on CDC Train.


Healthcare Professionals: Section 2 of CDC’s online training course about antibiotic stewardship is now available! Receive free CE. Create an account or log in to register:https://bit.ly/2Jt3yFD

No hay comentarios:

Publicar un comentario